# A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomised-phase-ii-study-of-modified-folfirinox-versus-gemcitabine-plus-nab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masato Ozaka,Kohei Nakachi,Satoshi Kobayashi,Akihiro Ohba,Hiroshi Imaoka,Takeshi Terashima,Hiroshi Ishii,Junki Mizusawa,Hiroshi Katayama,Tomoko Kataoka,Takuji Okusaka,Masafumi Ikeda,Naoki Sasahira,Haruo Miwa,Eishiro Mizukoshi,Naohiro Okano,Nobumasa Mizuno,Tomohisa Yamamoto,Yoshito Komatsu,Akiko Todaka,Ken Kamata,Masayuki Furukawa,Nao Fujimori,Akio Katanuma,Yukiko Takayama,Hidetaka Tsumura,Haruhiko Fukuda,Makoto Ueno,Junji Furuse |
| Citations | 87 |
| DOI | 10.1016/j.ejca.2022.12.014 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.ejca.2022.12.014 |
| OpenAlex ID | https://openalex.org/W4313256472 |
| PMID | 36652891 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Haruo Miwa](https://scholariq.org/researchers/haruo-miwa/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Paper topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.